(Q84073243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20399961%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

review article

1 reference

title

Regulatory T cells in cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20399961%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Dimitrios Mougiakakos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20399961%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Aniruddha Choudhury

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20399961%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Alvaro Lladser

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20399961%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Rolf Kiessling

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20399961%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

C Christian Johansson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20399961%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20399961%20AND%20SRC:MED&resulttype=core&format=json

Advances in Cancer Research

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20399961%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20399961%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

57-117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20399961%20AND%20SRC:MED&resulttype=core&format=json

IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Interleukin-10 in the regulation of T cell-induced colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

In vivo instruction of suppressor commitment in naive T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Origin of regulatory T cells with known specificity for antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

IDO activates regulatory T cells and blocks their conversion into Th17-like T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+ regulatory T cells: mechanisms of induction and effector function.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory cells and human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+CD25high regulatory cells in human peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Human CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Induction of transplantation tolerance via regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Tuning microenvironments: induction of regulatory T cells by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cancer; a biological approach. I. The processes of control

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Role of regulatory T cells in human diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Human Tumor-Derived Exosomes Selectively Impair Lymphocyte Responses to Interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cutting edge: Decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD8+CD28- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Development and activation of regulatory T cells in the human fetus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Imbalance of regulatory T cells in human autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CTLA-4 blockade: unveiling immune regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CTLA-4: new insights into its biological function and use in tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Costimulatory signals controlling regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Modulation of tryptophan catabolism by regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

1 reference

7 January 2021

CD8+ T suppressor cells are back to the game: are they players in autoimmunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Developmental regulation of Foxp3 expression during ontogeny.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

A Comparative Study between T Regulatory Type 1 and CD4+CD25+ T Cells in the Control of Inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein in patients with previously treated chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Immunosuppressor T cells in tumor bearing host

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Interleukin 2 signaling is required for CD4(+) regulatory T cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Increased expression of cyclooxygenase-2 and increased infiltration of regulatory T cells in tumors of patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Clinical significance of regulatory T cells in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Role of LAG-3 in regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cutting Edge: TGF- Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4+CD25+ T Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Homing to suppress: address codes for Treg migration.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Correlation of CXCL12 expression and FoxP3+ cell infiltration with human papillomavirus infection and clinicopathological progression of cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+CD25+ suppressor lymphocytes in the circulation of patients immunized against melanoma antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Increased intratumoral FOXP3-positive regulatory immune cells during interleukin-2 treatment in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Frequency and gene expression profile of regulatory T cells in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulation of immune responses by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Inducing and expanding regulatory T cell populations by foreign antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cutting Edge: Murine Vascular Endothelium Activates and Induces the Generation of Allogeneic CD4+25+Foxp3+ Regulatory T Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

FOXP3 defines regulatory T cells in human tumor and autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Homeostatic control of immunity by TCR peptide-specific Tregs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+CD25+ regulatory T cell repertoire formation shaped by differential presentation of peptides from a self-antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Human ovarian carcinoma cells generate CD4(+)CD25(+) regulatory T cells from peripheral CD4(+)CD25(-) T cells through secreting TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

NK cell apoptosis in coronary artery disease: relation to oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Aire regulates negative selection of organ-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T cells in the periphery

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Mature dendritic cells induce tumor-specific type 1 regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

FOXP3+CD4+CD25+ Adaptive Regulatory T Cells Express Cyclooxygenase-2 and Suppress Effector T Cells by a Prostaglandin E2-Dependent Mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: role of B7-H3 expression and antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Inhibition of activated/memory (CD45RO(+)) T cells by oxidative stress associated with block of NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Molecular mechanisms underlying FOXP3 induction in human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Oxidative stress and lymphocyte persistence: implications in immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

IMMUNOLOGICAL FUNCTION OF THE THYMUS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T cells: friend or foe in immunity to infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

A model for developmentally acquired thymus-dependent tolerance to central and peripheral antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Do suppressor T cells exist?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

A Requirement for Two Cell Types for Antibody Formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Oral tolerance in the absence of naturally occurring Tregs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Dysfunctional T regulatory cells in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Is FOXP3 a bona fide marker for human regulatory T cells?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Policing the regulators

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T cells and immune tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulation of the chemokine receptor CXCR4 by hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Fatal attraction: tumors beckon regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Special regulatory T-cell review: Regulation of immune responses--examining the role of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

IL-2 secretion by CD4+ T cells in vivo is rapid, transient, and influenced by TCR-specific competition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Central role of ILT3 in the T suppressor cell cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Toll-like receptor 2 controls expansion and function of regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

VEGFR2 is selectively expressed by FOXP3high CD4+ Treg.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Chemoimmunotherapy of Tumors: Cyclophosphamide Synergizes with Exosome Based Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Activation requirements for the induction of CD4+CD25+ T cell suppressor function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

A comparison of an anti-CD25 immunotoxin, Ontak and anti-CD25 microbeads for their ability to deplete alloreactive T cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Toll-like receptor signalling on Tregs: to suppress or not to suppress?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Human CD4+CD25+ Regulatory T Lymphocytes Inhibit Lipopolysaccharide-Induced Monocyte Survival through a Fas/Fas Ligand-Dependent Mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

How regulatory T cells work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Mechanisms of suppression by suppressor T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD4+ CD25+ Treg: divide and rule?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T-cell compartmentalization and trafficking

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

FOXP3 controls regulatory T cell function through cooperation with NFAT

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Functional and genetic analysis of two CD8 T cell subsets defined by the level of CD45RC expression in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Extracellular redox modulation by regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T cells in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Activated CD4+CD25+ T cells selectively kill B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Plasticity of CD4(+) FoxP3(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

FOXP3: not just for regulatory T cells anymore

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2810%2907003-X

7 January 2021

10.1016/S0065-230X(10)07003-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20399961%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference